Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland.

Czarnecka AM, Krawczyk T, Zdrozny M, Lubiński J, Arnold RS, Kukwa W, Scińska A, Golik P, Bartnik E, Petros JA.

Breast Cancer Res Treat. 2010 Jun;121(2):511-8. doi: 10.1007/s10549-009-0358-5. Epub 2009 Mar 6.

PMID:
19266278
2.

Mitochondrial NADH-dehydrogenase polymorphisms as sporadic breast cancer risk factor.

Czarnecka AM, Klemba A, Krawczyk T, Zdrozny M, Arnold RS, Bartnik E, Petros JA.

Oncol Rep. 2010 Feb;23(2):531-5.

PMID:
20043118
3.

Ser326Cys polymorphism in DNA repair genes hOGG1 in breast cancer women.

Romanowicz-Makowska H, Smolarz B, Makowski M, Połać I, Pertyński T.

Pol J Pathol. 2008;59(4):201-4.

PMID:
19391486
4.

Mitochondrial genotype and breast cancer predisposition.

Czarnecka AM, Krawczyk T, Plak K, Klemba A, Zdrozny M, Arnold RS, Kofler B, Golik P, Szybinska A, Lubinski J, Mossakowska M, Bartnik E, Petros JA.

Oncol Rep. 2010 Dec;24(6):1521-34.

PMID:
21042748
5.

Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population.

Kohaar I, Tiwari P, Kumar R, Nasare V, Thakur N, Das BC, Bharadwaj M.

Breast Cancer Res Treat. 2009 Mar;114(2):347-55. doi: 10.1007/s10549-008-0006-5. Epub 2008 Apr 14.

PMID:
18409070
6.

MDR1 C3435T polymorphism in patients with breast cancer.

Turgut S, Yaren A, Kursunluoglu R, Turgut G.

Arch Med Res. 2007 Jul;38(5):539-44. Epub 2007 Apr 26.

PMID:
17560460
7.

A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.

Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.

Breast Cancer Res Treat. 2007 Jan;101(1):73-81. Epub 2006 Jun 29. Erratum in: Breast Cancer Res Treat. 2007 Apr;102(2):249.

PMID:
16807674
8.

Analysis of p53 gene polymorphisms and protein over-expression in patients with breast cancer.

Akkiprik M, Sonmez O, Gulluoglu BM, Caglar HB, Kaya H, Demirkalem P, Abacioglu U, Sengoz M, Sav A, Ozer A.

Pathol Oncol Res. 2009 Sep;15(3):359-68. doi: 10.1007/s12253-008-9129-6. Epub .

PMID:
19048399
9.

Mitochondrial genetic background modifies breast cancer risk.

Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ.

Cancer Res. 2007 May 15;67(10):4687-94.

10.
11.

CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.

Chakraborty A, Murthy NS, Chintamani C, Bhatnagar D, Mohil RS, Sharma PC, Saxena S.

J Hum Genet. 2007;52(2):159-65. Epub 2007 Jan 18.

PMID:
17235448
12.

HER2 polymorphism and breast cancer risk in Portugal.

Pinto D, Vasconcelos A, Costa S, Pereira D, Rodrigues H, Lopes C, Medeiros R.

Eur J Cancer Prev. 2004 Jun;13(3):177-81.

PMID:
15167216
13.

Genetic polymorphism in ornithine decarboxylase and risk of breast cancer.

Brown I, Halliday S, Greig H, Heys SD, Wallace HM, Schofield AC.

Fam Cancer. 2009;8(4):307-11. doi: 10.1007/s10689-009-9237-9. Epub 2009 Feb 19.

PMID:
19225907
14.

CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.

Tüzüner BM, Oztürk T, Kisakesen HI, Ilvan S, Zerrin C, Oztürk O, Isbir T.

In Vivo. 2010 Jan-Feb;24(1):71-4.

PMID:
20133979
15.

Estrogen receptor alpha gene polymorphism and breast cancer.

Siddig A, Mohamed AO, Awad S, Hassan AH, Zilahi E, Al-Haj M, Bernsen R, Adem A.

Ann N Y Acad Sci. 2008 Sep;1138:95-107. doi: 10.1196/annals.1414.015.

PMID:
18837889
16.

A polymorphism in the promoter region of Ku70/XRCC6, associated with breast cancer risk and oestrogen exposure.

Willems P, De Ruyck K, Van den Broecke R, Makar A, Perletti G, Thierens H, Vral A.

J Cancer Res Clin Oncol. 2009 Sep;135(9):1159-68. doi: 10.1007/s00432-009-0556-x. Epub 2009 Feb 15.

PMID:
19219618
17.

Association of BTLA gene polymorphisms with the risk of malignant breast cancer in Chinese women of Heilongjiang Province.

Fu Z, Li D, Jiang W, Wang L, Zhang J, Xu F, Pang D, Li D.

Breast Cancer Res Treat. 2010 Feb;120(1):195-202. doi: 10.1007/s10549-009-0462-6. Epub 2009 Jul 8.

PMID:
19585237
18.

[Association of single nucleotide polymorphisms and haplotypes in DNA repair gene XRCC1 with susceptibility of breast cancer].

Jin MJ, Chen K, Zhang SS, Zhang YJ, Ren YJ, Xu H, Yao KY, Li QL, Ma XY.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2006 Jul;35(4):370-6. Chinese.

PMID:
16924699
19.

Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.

Inoue H, Shibuta K, Matsuyama A, Yoshinaga K, Sadanaga N, Ueo H, Barnard GF, Mori M.

Oncol Rep. 2005 Sep;14(3):707-12.

PMID:
16077979
20.

Contribution of XPD (Lys751Gln) and XRCC1 (Arg399Gln) polymorphisms in familial and sporadic breast cancer predisposition and survival: an Indian report.

Syamala VS, Syamala V, Sreedharan H, Raveendran PB, Kuttan R, Ankathil R.

Pathol Oncol Res. 2009 Sep;15(3):389-97. doi: 10.1007/s12253-008-9135-8. Epub .

PMID:
19051060
Items per page

Supplemental Content

Write to the Help Desk